Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/77282
COMPARTIR / EXPORTAR:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Invitar a revisión por pares abierta
Título

Lipoxin A4 impairment of apoptotic signaling in macrophages: Implication of the PI3K/Akt and the ERK/Nrf-2 defense pathways

AutorPrieto, Patricia CSIC ORCID; Cuenca, Jimena CSIC; Través, Paqui G. CSIC; Fernández-Velasco, María CSIC ORCID; Martín-Sanz, Paloma CSIC ORCID ; Boscá, Lisardo CSIC ORCID CVN
Fecha de publicación2010
EditorNature Publishing Group
CitaciónCell Death and Differentiation 17(7): 1179-1188 (2010)
ResumenLipoxin A4 (LXA4) is an endogenous lipid mediator that requires transcellular metabolic traffic for its synthesis. The targets of LXA4 on neutrophils are well described, contributing to attenuation of inflammation. However, effects of lipoxins on macrophage are less known, particularly the action of LXA4 on the regulation of apoptosis of these cells. Our data show that pretreatment of human or murine macrophages with LXA4 at the concentrations prevailing in the course of resolution of inflammation (nanomolar range) significantly inhibits the apoptosis induced by staurosporine, etoposide and S-nitrosoglutathione or by more pathophysiological stimuli, such as LPS/IFNγ challenge. The release of mitochondrial mediators of apoptosis and the activation of caspases was abrogated in the presence of LXA4. In addition to this, the synthesis of reactive oxygen species induced by staurosporine was attenuated and antiapoptotic proteins of the Bcl-2 family accumulated in the presence of lipoxin. Analysis of the targets of LXA4 identified an early activation of the PI3K/Akt and ERK/Nrf-2 pathways, which was required for the observation of the antiapoptotic effects of LXA4. These data suggest that the LXA 4, released after the recruitment of neutrophils to sites of inflammation, exerts a protective effect on macrophage viability that might contribute to a better resolution of inflammation. © 2010 Macmillan Publishers Limited All rights reserved.
DescripciónEl pdf del artículo es la versión pre-print.
Versión del editorhttp://dx.doi.org/10.1038/cdd.2009.220
URIhttp://hdl.handle.net/10261/77282
DOI10.1038/cdd.2009.220
Identificadoresdoi: 10.1038/cdd.2009.220
issn: 1350-9047
e-issn: 1476-5403
Aparece en las colecciones: (IIBM) Artículos




Ficheros en este ítem:
Fichero Descripción Tamaño Formato
Lipoxin A4.pdf945,06 kBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo

CORE Recommender

SCOPUSTM   
Citations

95
checked on 25-mar-2024

WEB OF SCIENCETM
Citations

92
checked on 24-feb-2024

Page view(s)

872
checked on 27-mar-2024

Download(s)

443
checked on 27-mar-2024

Google ScholarTM

Check

Altmetric

Altmetric


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.